(Q34650883)

3 August 2017

Immunoadsorption patients with multiple sclerosis: an open-label pilot study (English)

1 reference

3 August 2017

0 references

Moldenhauer A

1

1 reference

3 August 2017

Haas J

2

1 reference

3 August 2017

Wäscher C

3

1 reference

3 August 2017

Derfuss T

4

1 reference

3 August 2017

Hoffmann KT

5

1 reference

3 August 2017

Kiesewetter H

6

1 reference

3 August 2017

Salama A

7

1 reference

3 August 2017

1 August 2005

1 reference

European Journal of Clinical Investigation

3 August 2017

1 reference

3 August 2017

35

1 reference

3 August 2017

8

1 reference

3 August 2017

523-530

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

3 August 2017

1 reference

The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

Mechanisms of demyelination and tissue destruction in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

Late complications of immune deviation therapy in a nonhuman primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

Immunoadsorption: strategies for antigen elution and production of reusable adsorbents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

Current disease-modifying therapies in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

Quality of life in multiple sclerosis: influence of interferon-beta1 a (Avonex) treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

The genetics of multiple sclerosis. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

Multiple sclerosis: from basic immunopathology to immune intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

Role of complement in demyelination in vitro by multiple sclerosis serum and other neurological disease sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

Plasma exchange for severe attacks of inflammatory demyelinating diseases of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

Immunoadsorption, current status and future developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01518.X

10.1111/J.1365-2362.2005.01518.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference